Search
Designed to facilitate hit to lead optimization through structure activity relationship work
The availability of diverse and pharmacophorically relevant synthetic building blocks remains a critical success factor in the drug design process. Where key building blocks are not commercially available, in-house synthesis consumes vital time and can add considerable cost to the project.
Our focus is to provide medicinal chemists with the ideal building blocks for use in early-phase drug discovery in:
- Structure activity relationship (SAR) development
- Generating screening libraries for further hit identification/elaboration
Our extensive range of medicinally relevant building blocks are specifically designed for lead optimization through structure activity relationship (SAR) development.
Extended library files now include bioactives - Released September 2025
Monomers in the drug discovery process
Our solutions
- Enhances the pharmacophoric profile of your target molecules
- Facilitates the full breadth of chemical synthesis techniques
- Enables systematic exploration of structural diversity space
- Provides easier interpretation of SAR
Features and benefits
- Over 25,000 building blocks containing more than 300 different heterocyclic ring systems
- Support all synthetically useful functional groups
- Provide all possible ring regioisomers
- Compounds have minimal additional substitution
Resources
For Research Use Only. Not for use in diagnostic procedures.